CEO of SFDA Discusses “Regulatory Pathways: Balancing Innovation and Safety” at the Global Healthspan Summit 2025
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, contributed his insights to a prominent panel discussion on “Regulatory Pathways: Balancing Innovation…